Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy.
暂无分享，去创建一个
D. Carbone | S. Kulp | P. Shields | G. Otterson | M. Phelps | D. Spakowicz | Yizhen Guo | C. Coss | T. Mace | M. Grogan | E. Bertino | C. Presley | K. He | Lai Wei | Latha P. Ganesan | D. Owen | A. Johns | S. Patel | Mingjia Li | G. Lopez | T. Haddad | Yiping Yang | Daniel J. Spakowicz